Title |
Investigating the efficacy of non-invasive vagus nerve stimulation in treating drug-resistant epilepsy
|
Authors |
Daleena Prathiba Madda1, Sruthi Vempatapu2,* & Sasikanth Kanaganuru3
|
Affiliation |
1Department of General Medicine, New Vara Hospital, Hyderabad, Telangana, India; 2Department of Emergency Medicine, Yashoda hospitals, Hyderabad, Telangana, India; 3Department of General Medicine, Apollo Hospitals, Hyderabad, Telangana, India; *Corresponding author
|
|
Daleena Prathiba Madda - E-mail: daleenaprathiba@gmail.com
|
Article Type |
Research Article
|
Date |
Received June 30, 2025; Revised June 30, 2025; Accepted June 30, 2025, Published June 30, 2025
|
Abstract |
Drug-resistant epilepsy (DRE) affects approximately 30% of individuals with epilepsy who do not respond to antiepileptic drugs. This randomized controlled trial evaluated the efficacy of non-invasive vagus nerve stimulation (nVNS) in 120 DRE patients. Over 12 weeks, the intervention group showed a 45% reduction in seizures and a 30% improvement in quality of life, both statistically significant. Minor side effects included headaches and neck discomfort. nVNS appears to be a safe and effective adjunctive therapy for managing DRE. |
Keywords |
Non-invasive vagus nerve stimulation, drug-resistant epilepsy, seizure frequency, quality of life, neuromodulator, alternative therapy.
|
Citation |
Madda et al. Bioinformation 21(6): 1551-1554 (2025)
|
Edited by |
Hiroj Bagde MDS, (PhD), PGDCR, PGDHHM, PGDL, PGDM
|
ISSN |
0973-2063
|
Publisher |
|
License |
This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.
|
|